Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-29

Clinical Trial Update: Dolutegravir in Reservoirs [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating dolutegravir in reservoirs for HIV was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: Emory University | Conditions: HIV | Phase 4 | Status: TERMINATED | Results posted: 2022-12-29